Replies to post #145276 on Biotech Values

[DewDiligence]

Does the fact that the GSK/THRX drug is QD vs. a BID generic lessen these concerns to some degree?

Yes, to a very small degree, IMHO.

[DewDiligence]

GSK/THRX submit MAA for Breo/Relvar (f/k/a Relovair, “Son of Advair):

http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/07/breo-copd-asthma-gsk-theravance.html

[DewDiligence]

THRX/GSK ‘Son of Advair’ receives PDUFA date of 5/12/13 (standard review):

http://finance.yahoo.com/news/gsk-theravance-announce-fda-acceptance-080000574.html